The increased levels of UCHL1 in the CSF of patients with ALS might reflect its release as a consequence of axonal degeneration, whereas its reduction in post-mortem tissue could be secondary to axonal loss.47 Here, UCHL1 is linked to amyotrophic lateral sclerosis.